Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic inflammatory myopathies

A A Amato1, R J Barohn

  • 1Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7883, USA.

Neurologic Clinics
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumption of coffee or caffeine and serum concentration of inflammatory markers: A systematic review.

Critical reviews in food science and nutrition·2017
Same author

Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2016
Same author

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

Neurology·2011
Same author

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Brain : a journal of neurology·2009
Same author

Inclusion body myositis: old and new concepts.

Journal of neurology, neurosurgery, and psychiatry·2009
Same author

Evaluation and treatment of inflammatory myopathies.

Journal of neurology, neurosurgery, and psychiatry·2009
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Idiopathic inflammatory myopathies, including dermatomyositis, polymyositis, and inclusion body myositis, are distinct autoimmune conditions. This review covers their features, recent advances, and treatment strategies.

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Idiopathic inflammatory myopathies (IIMs) encompass dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM).
  • These conditions are characterized by distinct clinical, histological, and pathogenic profiles.
  • DM and PM may present with overlapping features of other autoimmune connective tissue diseases.

Purpose of the Study:

  • To review the characteristic features of major IIMs.
  • To update on recent developments in the understanding and management of IIMs.
  • To provide a treatment framework for clinicians.

Main Methods:

  • Literature review of characteristic features of IIMs.
  • Synthesis of recent research findings and clinical developments.

Related Experiment Videos

  • Development of a treatment guideline based on current evidence.

    • Main Results:

    • Dermatomyositis, polymyositis, and inclusion body myositis are clinically, histologically, and pathogenically distinct.
    • Overlapping autoimmune features can occur in DM and PM.
    • Current literature provides evolving insights into IIM pathogenesis and therapeutic options.

    Conclusions:

    • Accurate diagnosis and differentiation of IIM subtypes are crucial.
    • Understanding recent advancements aids in improved patient outcomes.
    • A structured treatment approach is essential for managing these complex autoimmune conditions.